GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen upbeat on promising cannabis skincare test results

Mon, 25th Mar 2019 11:39

(Sharecast News) - Integumen announced positive results from further tests in formulations on Monday, all of which contained low-concentrations of hemp-derived cannabinoid (CBD) oils.The AIM-traded firm said the formulations increased production of pro-collagen, and indicated a reduction of inflammation on 'Labskin', leading to a soothing effect on irritated and sore skin.It explained that pro-collagen had been shown to improve the "youthfulness" of skin appearance, and was a precursor of collagen - the protein that adds strength and support to body tissue.The amount of pro-collagen production could be directly measured, as no additional collagen was added to the Labskin model.Inflammation, meanwhile, could be caused by a variety of reasons ranging from bacterial infection to irritation from harsh skin products, Integumen explained.It said Labskin was capable of releasing chemical markers that indicated inflammation damage occurring on the skin test model.The trial data showed that formulations containing hemp-derived CBD oil, in low concentrations, reduced the release of those inflammation markers, indicating a soothing effect on sore skin.Ingegume's updates on 7 January and 20 February noted that Cellulac, which is 9.35% owned by Integumen, had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the 'STOER For Men' range of cosmetics."Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers," said Integumen chief executive officer Gerard Brandon."With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it."Further tests and product approvals were still required before consideration of launching an extension to the range of STOER For Men skin care products, Brandon explained."Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products."
More News
19 Sep 2018 14:20

Integumen Receives Payment Demand From Former Director

LONDON (Alliance News) - Integumen PLC said Wednesday it received demand for payment by former director Donald Nicholson and Mercuriali Ltd for services provided to the company."Whilst

Read more
6 Jul 2018 08:32

Integumen Will Not Proceed With Reverse Takeover Of Cellulac

LONDON (Alliance News) - Integumen PLC said Friday it has decided against the reverse takeover of Cellulac PLC but "remains in discussions" with the company to agree on an alternative it

Read more
29 Jun 2018 13:13

Integumen's Discussions Over Cellulac Acquisition Continue

LONDON (Alliance News) - Healthcare firm Integumen PLC said on Friday discussions over its acquisition of Cellulac and due diligence are ongoing, as is the process of raising funds for the in are

Read more
27 Mar 2018 07:27

Swiss stocks - Factors to watch on March 27

ZURICH, March 27 (Reuters) - The Swiss blue-chip SMI was seen opening 1.2 percent higher at 8,613 points on Tuesday, according to premarket indications by bank Julius are some

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.